SANTA ANA, Calif. — BLS Pharma sued Inovio Pharmaceuticals and Genetronics for $77 million, claiming they refused to sell it proprietary elements of a needleless injector for testosterone injection after learning it would be used for transgender people, in Orange County Court.
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.

